ARCHIVES

Central Oncology Group Phase Out Approved; Board Impressed By Unanimous CCIRC Vote

This article is from The Cancer Letter archive.

Vol. 02 No. 14 | April 2, 1976

Download PDF Visit The Full Archive

Related Articles

Includes 8-page April 2002 Business & Regulatory Report.

May 3, 2002

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

NIH News: NTP To test Herbs for Toxicity

August 13, 1999

Professional Groups Agree On Colon Cancer Screening Guidelines.

March 7, 2008

Dietary Interventions Reduce Breast Cancer Risk In Trials

May 27, 2005

DCDDP Final Report; 3,557 Cancers, 90% By Mammography

July 9, 1982